OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sodium Glucose Cotransporter-2 Inhibitors: Spotlight on Favorable Effects on Clinical Outcomes beyond Diabetes
Věra Čertíková Chábová, Oskar Zakiyanov
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2812-2812
Open Access | Times Cited: 12
Věra Čertíková Chábová, Oskar Zakiyanov
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2812-2812
Open Access | Times Cited: 12
Showing 12 citing articles:
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
Lucia Scisciola, Fatemeh Taktaz, Rosaria Anna Fontanella, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Lucia Scisciola, Fatemeh Taktaz, Rosaria Anna Fontanella, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Association between Obstructive Sleep Apnea and Heart Failure in Adults—A Systematic Review
Agnieszka Polecka, Natalia Olszewska, Łukasz Danielski, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6139-6139
Open Access | Times Cited: 15
Agnieszka Polecka, Natalia Olszewska, Łukasz Danielski, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6139-6139
Open Access | Times Cited: 15
Antifibrotic effects of sodium-glucose cotransporter-2 inhibitors: A comprehensive review
Neda Shakour, Shima Karami, Mehrdad Iranshahi, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 18, Iss. 1, pp. 102934-102934
Closed Access | Times Cited: 12
Neda Shakour, Shima Karami, Mehrdad Iranshahi, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 18, Iss. 1, pp. 102934-102934
Closed Access | Times Cited: 12
Controversies in Perioperative Medication Management
Kenneth C. Cummings, Maureen Keshock, Adriana D. Oprea
International Anesthesiology Clinics (2025)
Closed Access
Kenneth C. Cummings, Maureen Keshock, Adriana D. Oprea
International Anesthesiology Clinics (2025)
Closed Access
The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?
Michail Koutentakis, Jakub Kuciński, Damian Świeczkowski, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 11, pp. 465-465
Open Access | Times Cited: 9
Michail Koutentakis, Jakub Kuciński, Damian Świeczkowski, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 11, pp. 465-465
Open Access | Times Cited: 9
Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes
Vincenzo Maria Monda, Sandro Gentile, Francesca Porcellati, et al.
Advances in Therapy (2022) Vol. 39, Iss. 11, pp. 4837-4846
Open Access | Times Cited: 11
Vincenzo Maria Monda, Sandro Gentile, Francesca Porcellati, et al.
Advances in Therapy (2022) Vol. 39, Iss. 11, pp. 4837-4846
Open Access | Times Cited: 11
Relationship of vitamin D deficiency to cardiovascular disease and glycemic control in patients with type 2 diabetes mellitus: The Silesia Diabetes-Heart Project
Hanna Kwiendacz, Katarzyna Nabrdalik, Agata M. Wijata, et al.
Polskie Archiwum Medycyny Wewnętrznej (2023)
Open Access | Times Cited: 1
Hanna Kwiendacz, Katarzyna Nabrdalik, Agata M. Wijata, et al.
Polskie Archiwum Medycyny Wewnętrznej (2023)
Open Access | Times Cited: 1
TorS ‐ Reframing a rational for type 2 diabetes treatment
Jacob Bar‐Tana
Diabetes/Metabolism Research and Reviews (2023) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Jacob Bar‐Tana
Diabetes/Metabolism Research and Reviews (2023) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Considerations for Choosing First-Line Urate-Lowering Treatment in Older Patients with Comorbid Conditions
Eun Ha Kang
Drugs & Aging (2022) Vol. 39, Iss. 12, pp. 923-933
Closed Access | Times Cited: 2
Eun Ha Kang
Drugs & Aging (2022) Vol. 39, Iss. 12, pp. 923-933
Closed Access | Times Cited: 2
Sodium‐glucose cotransporter‐2 inhibitor‐induced euglycemic diabetic ketoacidosis: A case report
Jingjing Han, Shuo Xie, Hongmei Jiao
Journal of Clinical Pharmacy and Therapeutics (2022) Vol. 47, Iss. 9, pp. 1482-1485
Closed Access | Times Cited: 1
Jingjing Han, Shuo Xie, Hongmei Jiao
Journal of Clinical Pharmacy and Therapeutics (2022) Vol. 47, Iss. 9, pp. 1482-1485
Closed Access | Times Cited: 1
Uso dos Inibidores do Transportador 2 de Sódio-Glicose no tratamento da Insuficiência Cardíaca: uma revisão de literatura
Larissa Toloy Bigaran, Vivian Saab, Thiago Cabral Ferreira, et al.
Research Society and Development (2022) Vol. 11, Iss. 6, pp. e42411629361-e42411629361
Open Access
Larissa Toloy Bigaran, Vivian Saab, Thiago Cabral Ferreira, et al.
Research Society and Development (2022) Vol. 11, Iss. 6, pp. e42411629361-e42411629361
Open Access
Targeting High Glucose-Induced Epigenetic Modifications at Cardiac Levels: The Role of SGLT2 and SGLT2 Inhibitors
Lucia Scisciola, Fatemeh Taktaz, Rosaria Anna Fontanella, et al.
Research Square (Research Square) (2022)
Open Access
Lucia Scisciola, Fatemeh Taktaz, Rosaria Anna Fontanella, et al.
Research Square (Research Square) (2022)
Open Access
